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The problem of malignant melanoma is important in the 
United States, in the world as a whole, and particularly in 
Hawaii with its high levels of ultraviolet radiation. It is esti-
mated that 32,000 Americans will develop melanoma and 
6,800 will die of this tumor in I993. Melanoma is now the 
seventh most frequent cancer in the United States. It is more 
common than ovarian, cervical, CNS cancer and leukemia1• 
Both incidence and mortality from melanoma are rapidly 
increasing. The incidence of melanoma has consistently 
increased 6% a year and the death rate has increased 2% a 
year since I950. At current rates, one in 400 will die of this 
tumor. Should this rate of increase continue, by the year 
2000, it is estimated that one in 75 Americans will develop 
melanoma during a lifetime. The highest melanoma incidence 
in the U.S. is found in Hawaii. Melanoma is increasing faster 
than any other cancer in the United States and all over the 
world2• 
Gender-specific epidemiologic issues 
Most studies show an overall slight preponderance of men 
over women developing melanoma. The rate of melanoma is 
increasing most rapidly in persons under the age of 40. 
Women predominate with a 3:2 ratio from ages 20 to 29 and a 
2:1 ratio from ages 30 to 39. Melanoma is currently the most 
frequent of all cancers in women ages 25 to 29, and second 
(after breast cancer) in women ages 30 to 34. 
Above the age of 40, these curves cross with more men 
developing melanoma than women. By age 80, men outnum-
ber women almost 2:1 in terms of developing this cancer. 
Similar findings are being noted worldwide. The reasons for 
these differences in gender-incidence are as yet unknown. 
Prognostic factors 
The most important factor that influences survival in per-
sons with melanoma is how deep the lesion has penetrated 
into the skin. A small difference in tumor thickness can be 
critical. Almost all persons with melanoma less than 0.75 mm 
(1132) will survive while less than half will survive when the 
lesion is greater than 3.0 mm (118 inch) in thickness. Other 
factors that influence survival include whether the tumor is 
localized or has spread (stage), if it is eroded and/or has bled 
(ulceration), and where on the body it is located (anatomic site). 
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There are significant differences in survival in men versus 
women who have developed melanoma. After correcting for 
other prognostic factors, women have a significantly 
improved 5- and 10-year survival over men. Data from 1,143 
melanoma patients from New York University Melanoma 
Cooperative Group show a 10-year survival of 83% in women 
versus 73% in men. (Figure 1) This finding of differences in 
survival by gender are supported by many other studies in the 
United States and worldwide. 
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Figure 1: Comparison of 10-year survival in male and 
female patients. New York University Cooperative Group 
unpublished data. 
Several reasons have been proposed for this difference in 
survival by gender. First, melanoma is a cancer that is hor-
monally influenced. Progesterone and estrogen may favorably 
influence in persons with this tumor. Second, men most often 
develop their melanoma on the upper back while women 
often experience lesions on their legs. The difficulty in seeing 
melanoma arising on the back may result in a delay in diagno-
sis3. In fact studies have suggested that men tend to delay see-
ing a physician for evaluation of a suspicious lesion as com-
pared to women. This delay lets the melanoma progress 
resulting in thicker, more often ulcerated tumors that may be 
more likely to have spread prior to the initial visit to the doc-
tor. These factors would also contribute to a lower rate of sur-
vival in men. 
Trends in mortality for melanoma also show gender-specif-
ic findings. The overall death rate for melanoma in the United 
States is now 2.7 per 100,000. However, the rate in men is 3.2 
per 100,000 versus 2.2 per 100,000 in women. Data from the 
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Editor's note: 
Christine Trecker is a 20-year resident of Oahu. She lives on 
the windward coast with her husband and daughter and enjoys 
the indoors and outdoors. Her background is in marketing 
research and advertising. 
She realized the need for this type of publication for our resi-
dents and our visitors as well. All profits from the book sales go 
to the Friends of Foster Kids. Books are available at Liberty 
House and most bookstores .. 
Norman Goldstein MD 
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NEW ULTRAVIOLET MONITORING (continuedfrompage 116) 
scientific and nontraditional settings. The EMTEC Uviscan™ 
PDU is a public display unit approximately 1 meter square 
(Figure 1). Data on UV intensity are displayed as individual 
" time-to-burn" values for each skin type. (The EMTEC 
Uviscan™ PDU has been calibrated for skin types 1 to 4.) The 
unit's display rotates through 360° to ensure maximum visibility 
from all surrounding areas. A measurement of UV is made at 
the beginnning of a series of 4 rotations; the unit then displays 
the estimated time-to-bum for each skin type. When the cycle is 
complete, the UV ~ensor takes a new measurement and the dis-
play values for each skin type are updated. Measurements are 
made every 4 minutes, though this rate can be adjusted to suit 
the unit's particular application. The unit is intended for instal-
lation in public recreation areas such as beaches and play-
grounds; Figure 1 illustrates the positioning of the EMTEC 
Figure 1: Copyright EMTEC Ltd 
Uviscan™ PDU above a lifeguard station on Waikiki Beach in 
Hawaii, one of the first sites to employ EMTEC technology . 
The unit has been designed so that the display is visible from up 
to 100 meters away, even under the most glaring conditions. 
Two similar but smaller devices are presently being 
designed: The EMTEC Uviscan™ Professional and the 
EMTEC Uviscan™ Domestic. The Professional has been 
designed for use in commercial establishments with high popula-
tion density, where long-distance visibility is not essential. 
Hotel swimming pools and tennis courts are 2 typical applica-
tions for this device. The EMTEC Domestic has been designed 
for the home environment, again for use near the swimming 
pool or during children's backyard playtime. 
EMTEC technology also makes possible accurate personal 
UV monitoring. The pocket-size EMTEC Uviscan™ Personal is 
an intelligent device that allows the user to insert his or her skin 
type, suncreen SPF number and the amount of sun exposure per 
day. The Uviscan Personal then displays the estimated time-to-
burn. Every 30 seconds the unit takes new measurements and 
updates the display accordingly. 
A final product is designed for use on children. It is non-pro-
grammable, allows for only 1 skin type (type 1) and the parent 
is required to apply a sunscreen of SPF 15 or higher to the child. 
In this manner, EMTEC hopes to encourage a relationship 
between the regular use of sunscreen and an adequate SPF num-
ber for the child's protection against the sun. The unit measures 
and records accumulated UV exposure and displays the accu-
mulated dose in the form of up to "10 suns" on a liquid crystal 
display. When the tenth sun has appeared, an alarm sounds 
which means that the child should be taken indoors in order to 
avoid overexposure. 
Summary 
The EMTEC sensors include a range of products appropriate 
for different uses in different locations. It is envisioned that this 
technology, used in conjunction with public health education, 
will have a significant impact on sun-oriented behavior. The 
message being delivered will be accompanied by quantified 
information directly useful for gauging sun exposure. 
With the technological elements now in use, a low-cost, 
ground-based UV monitoring network can be established. 
EMTEC is actively establishing such a facility in association 
with interested organizations on a worldwide basis. 
Dissemination of this information will raise public awareness of 
skin cancer issues and assist institutions in vital research. 
The development of the EMTEC sensor marks a new era in 
UV monitoring and places an emphasis on the responsible use 
of products based on new technology. 
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GENDER-RELATED ISSUES IN MALIGNANT MELANOMA (continued from page 124) 
Centers for Disease Control (CDC) show that the death rate 
from melanoma in women increased 21% from 1973 to 1988 
while the death rate for men increased 50%6 • In fact, according 
to the CDC, the death rate for melanoma in men is increasing 
faster than for any other cancer. 
Conclusion 
The incidence of melanoma is increasing most rapidly in 
women under 40 whereas the death rate from this tumor is rising 
more rapidly in older men. Because the only cure for this cancer 
remains early detection and treatment, increased public education 
and promotion of awareness among both women and men are 
needed in order to minimize the hazards from melanoma. 
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Editorial comment: 
Dr. Rigel is a "world authority" on melanoma. 
Norman Goldstein MD 
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